References
- Robertson CF, Rubinfeld AR, Bowes G. Death from asthma in Victoria: A 12-month survey. Med J Aust 1990;152:511–517.
- Fitzpatrick MF, Engleman H, Whyte KF. Morbidity in nocturnal asthma: Sleep quality and daytime cognitive performance of normal subjects. Thorax 1991;46:569–573.
- Weersink EJ, Van Zomeren EH, Koeter GH. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med 1997;156:1144–1150.
- Bender BG, Annett RD. Neurophysiological outcomes of nocturnal asthma. Chronobiol Int 1999;16:695–710.
- Diette GB, Markson L, Skinner EA. Nocturnal asthma in children affects school attendance, school performance, and parents’ work attendance. Arch Pediatr Adolesc Med 2000;154:923–928.
- Dethlefsen U, Repges R. Eines neues Therapieprincip bei nächtlichen Asthma. Med Klinik 1985;80:44–47.
- Bussemer T, Bodmeier RA. Drug delivery: Pulsatile systems. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker 2007;1:1287–1297.
- MaGruder PR, Barclay B, Wong PSL, Theeuwes F. Composition comprising salbutamol. US Patent. 1988; 4,751,071.
- Culter N, Anders R, Stanford S, Stramed J, Awan N, Bultas J, Lahari A, Woroszylska M. Placebo-controlled evaluation of three doses of a controlled-onset, extended release formulation of verapamil in the treatment of stable angina pectoris. Am J Cardiol 1995;75:1102–1106.
- Ueda S, Hata T, Asakura S, Yamaguchi H, Ueda Y. Development of a novel drug release system, time controlled explosion system (TES). Part 1. Concept and design. J Drug Target 1994;2:35–44.
- Narisawa S, Nagata M, Hirakawa Y, Kobayshi M, Yoshino H. An organic acid-induced sigmoidal release system for oral controlled release preparations. Permeability enhancement of Eudragit RS coating led by the physicochemical interaction with organic acid. J Pharm Sci 1996;85:184–188.
- Karavas E, Georgarakis E, Bikiaris D. Felodipine nanodispersions as active core for predictable Pulsatile chronotherapeutics using PVP/HPMC blends as coating layer. Int J Pharm 2006;313:189–197
- Nazzal S, Nazzal M, El-Malah Y. A novel texture-probe for the simultaneous and real-time measurement of swelling and erosion rates of matrix tablets. Int J Pharm 2006; 330:195–198.
- El-Malah Y, Nazzal S. Hydrophilic matrices: Application of Placket-Burman screening design to model the effect of POLYOX-carbopol blends on drug release. Int J Pharm 2006;309:163–170.
- El-Malah Y, Khanfar NM, Nazzal S. D-optimal mixture design: Optimization of ternary matrix blends for controlled zero-order drug release from oral dosage forms. Drug Dev Ind Pharm 2006;32:1207–1218.
- Kibbe AH. Carbomer. In: Kibbe AH, editor. Handbook of pharmaceutical excipient. In: American Pharmaceutical Association, 3rd ed. Washington, DC: Pharmaceutical Press; 2000:100–300.
- Chan HK, Chew NYK. Excipients: Powders and solid dosage forms. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker 2007;1:1646–1655.
- Alderman DA. A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms. Int J Pharm Tech Prod Mfr 1984;5:1–9.
- Bowstra JA, Junginger HE. Hydrogel. In: Swarbrick J, Boylan JC, editors. Encyclopedia of Pharmaceutical Technology. vol. 7. New York: Marcel Dekker; 1993:441–465.
- Jamazad S, Tutunji L, Fassihi R. Analysis of macromolecular changes and drug release from hydrophilic matrix systems. Int J Pharm 2005;292:75–85.
- Siepmann J, Streubel A, Peppas NA. Understanding and prediction drug delivery from hydrophilic matrix tablets using the sequential layer model. Pharm Res 2002;19:306–313.
- Fan LT, Singh SK. Controlled release. Berlin: Springer-Verlag; 1989.
- Ju RTC, Nixon PR, Patel MV, Tong DM. Drug release from hydrophilic matrices. 1. New scaling laws for predicting polymer and drug release based on the polymer disentanglement concentration and the diffusion layer. J Pharm Sci 1995;84:1464–1477.
- Ju RTC, Nixon PR, Patel MV. Diffusion coefficient of polymer chains in the diffusion layer adjacent to a swollen hydrophilic matrix. J Pharm Sci 1997;86:1293–1298.